ライフサイエンスコーパス: chronic fatigue syndrome

1 marizes the current state of knowledge about chronic fatigue syndrome.

2 ilure, does not seem to be beneficial in the chronic fatigue syndrome.

3 versus relaxation therapy for patients with chronic fatigue syndrome.

4 re important in both chronic fatigue and the chronic fatigue syndrome.

5 There is mild hypocortisolism in chronic fatigue syndrome.

6 e one factor contributing to the symptoms of chronic fatigue syndrome.

7 a group of well-characterized patients with chronic fatigue syndrome.

8 ndromes such as irritable bowel syndrome and chronic fatigue syndrome.

9 sess suicidality adequately in patients with chronic fatigue syndrome.

10 tion syndrome, heat intolerance, and perhaps chronic fatigue syndrome.

11 has been documented in both fibromyalgia and chronic fatigue syndrome.

12 een also documented in both fibromyalgia and chronic fatigue syndrome.

13 en parvovirus and Still's disease as well as chronic fatigue syndrome.

14 -traumatic stress disorder, and possibly the chronic fatigue syndrome.

15 e autoantibodies in sera of 60 patients with chronic fatigue syndrome.

16 tory evidence for an autoimmune component in chronic fatigue syndrome.

17 xtent, physical disability for patients with chronic fatigue syndrome.

18 case note entry) and received a diagnosis of chronic fatigue syndrome.

19 plus CBT and SMC plus GET for patients with chronic fatigue syndrome.

20 ing therapy (APT) plus SMC and SMC alone for chronic fatigue syndrome.

21 rt in perpetuating fatigue and disability in chronic fatigue syndrome.

22 in alleviating symptoms of depression and in chronic fatigue syndrome.

23 ced Motivation approached levels observed in chronic fatigue syndrome.

24 irritable bowel syndrome, fibromyalgia, and chronic fatigue syndrome.

25 be associated with human prostate cancer and chronic fatigue syndrome.

26 cialist medical care (SMC) for patients with chronic fatigue syndrome.

27 n association with human prostate cancer and chronic fatigue syndrome.

28 aretrovirus linked to prostate carcinoma and chronic fatigue syndrome.

29 n between the human gammaretrovirus XMRV and chronic fatigue syndrome.

30 rosis, postpoliomyelitis, poststroke, and in chronic fatigue syndrome.

31 onal diagnostic criteria for neurasthenia or chronic fatigue syndrome.

32 actor for postinfectious irritable bowel and chronic fatigue syndromes.

33 d psychological distress in chronic pain and chronic fatigue syndromes.

34 d costs attributable to the chronic pain and chronic fatigue syndromes.

35 ts with prostate cancer and in patients with chronic fatigue syndromes.

36 igue and physical functioning in people with chronic fatigue syndrome 1 year after randomisation.

37 The chronic fatigue syndrome also presents problems in defin

38 n association with human prostate cancer and chronic fatigue syndrome, although these associations ar

39 ticipants meeting international criteria for chronic fatigue syndrome and 329 participants meeting Lo

40 ns from 121 consecutive clinic patients with chronic fatigue syndrome and 64 comparison subjects with

41 diagnostic biomarker of MMF in patients with chronic fatigue syndrome and cognitive dysfunction.

42 ing has confirmed an association between the chronic fatigue syndrome and orthostatic intolerance; ho

43 sorders, coronary heart disease, cancer, and chronic fatigue syndrome and those remaining on their in

44 We sought predictors of both acute and chronic fatigue syndromes and mood disorders from clinic

45 , 'Dopamine and fibromyalgia', 'Dopamine and chronic fatigue syndrome' and 'Dopamine and irritable bo

46 l and nuclear envelope proteins was found in chronic fatigue syndrome, and an increased prevalence of

47 ntidepressants for irritable bowel syndrome, chronic fatigue syndrome, and chronic back pain were sel

48 l presentation, evaluation, and prognosis of chronic fatigue syndrome are discussed.

49 ed to SMC to moderately improve outcomes for chronic fatigue syndrome, but APT is not an effective ad

50 erapy is an effective and safe treatment for chronic fatigue syndrome, but it is therapist intensive

51 increased all-cause mortality in people with chronic fatigue syndrome, but our findings show a substa

52 herapy (GET) can be effective treatments for chronic fatigue syndrome, but patients' organisations ha

53 mors and in blood samples from patients with chronic fatigue syndrome, but these findings have not be

54 Cognitive behavior therapy for chronic fatigue syndrome can produce some lasting benefi

55 oymentloss in a case series of patients with Chronic Fatigue Syndrome (CFS) after the infection.

56 et al's 1994 criteria were used to diagnose chronic fatigue syndrome (CFS) and idiopathic chronic fa

57 Fibromyalgia (FM) and chronic fatigue syndrome (CFS) are associated with subst

58 Patients with chronic fatigue syndrome (CFS) are more likely than heal

59 present in the blood of 67% of patients with chronic fatigue syndrome (CFS) compared with 3.7% of hea

60 Recent reports showed many patients with chronic fatigue syndrome (CFS) harbor a retrovirus, xeno

61 Gulf War Illness (GWI) and Chronic Fatigue Syndrome (CFS) have similar profiles of

62 ophysiology, and treatment of postinfectious chronic fatigue syndrome (CFS) in adolescents.

63 orrectly associated with prostate cancer and chronic fatigue syndrome (CFS) in recent years.

64 tress disorder (PTSD) and illness resembling chronic fatigue syndrome (CFS) in the entire population

65 Chronic fatigue syndrome (CFS) is a complex, heterogeneo

66 Chronic fatigue syndrome (CFS) is a debilitating disease

67 Myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS) is a debilitating multisy

68 Chronic fatigue syndrome (CFS) is a disabling condition

69 Chronic fatigue syndrome (CFS) is a multisystem disorder

70 Chronic fatigue syndrome (CFS) is a serious systemic ill

71 Chronic fatigue syndrome (CFS) is an important public he

72 Chronic fatigue syndrome (CFS) is associated with a dysr

73 diagnosis of myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS) is based on clinical crit

74 Chronic fatigue syndrome (CFS) is characterized by sever

75 man and Das Gupta, analyzed DNA samples from chronic fatigue syndrome (CFS) patients and healthy cont

76 ported differences in the immune function of chronic fatigue syndrome (CFS) patients are detectable i

77 Chronic fatigue syndrome (CFS) remains poorly understood

78 with acute sinusitis (n = 25), subjects with chronic fatigue syndrome (CFS) with nonallergic rhinitis

79 ory cytokine, is suspected to play a role in chronic fatigue syndrome (CFS).

80 e dysfunction may be common in patients with chronic fatigue syndrome (CFS).

81 n measures of myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS).

82 been used in the treatment and management of chronic fatigue syndrome (CFS).

83 laint of fatigue, a small number suffer from chronic fatigue syndrome (CFS).

84 h published criteria used to define cases of chronic fatigue syndrome (CFS).

85 s similar to those reported by patients with chronic fatigue syndrome (CFS).

86 e living with myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS).

87 er found in a high percentage of humans with chronic fatigue syndrome (CFS).

88 d mononuclear cells (PBMCs) of patients with chronic fatigue syndrome (CFS).

89 to be present in the blood of patients with chronic fatigue syndrome (CFS).

90 (XMRV), have been controversially linked to chronic fatigue syndrome (CFS).

91 rauma appears to be a potent risk factor for chronic fatigue syndrome (CFS).

92 Certain infections can trigger chronic fatigue syndromes (CFS) in a minority of people

93 ticipants were recruited from six specialist chronic fatigue syndrome clinics in the UK National Heal

94 nces in understanding the pathophysiology of chronic fatigue syndrome continue to demonstrate the inv

95 dds ratio, 2.32 [95% CI, 1.02 to 5.27]); the chronic fatigue syndrome (deployed, 1.6%; nondeployed 0.

96 outcome measures included fibromyalgia, the chronic fatigue syndrome, dermatologic conditions, dyspe

97 Patients with chronic fatigue syndrome experience significant function

98 Conditions examined were the chronic fatigue syndrome, fibromyalgia, the irritable bo

99 We identified 2147 cases of chronic fatigue syndrome from CRIS and 17 deaths from Ja

100 for Health and Care Excellence criteria for chronic fatigue syndrome from two secondary-care clinics

101 Although chronic fatigue syndrome has significant symptom overlap

102 tober 2012 as part of the Norwegian Study of Chronic Fatigue Syndrome in Adolescents: Pathophysiology

103 ated mortality in individuals diagnosed with chronic fatigue syndrome in secondary and tertiary care

104 kinsonism', 'Functional somatic syndromes', 'Chronic fatigue syndrome', 'Irritable bowel syndrome', '

105 Chronic fatigue syndrome is a controversial condition es

106 s exist across many domains, suggesting that chronic fatigue syndrome is a heterogeneous condition of

107 Chronic fatigue syndrome is an illness characterized by

108 Myalgic encephalomyelitis/chronic fatigue syndrome is an unexplained debilitating

109 Chronic fatigue syndrome is diagnosed on the basis of sy

110 The prevalence of chronic fatigue syndrome is much less than that of fibro

111 arch on the pathophysiology and treatment of chronic fatigue syndrome is reviewed.

112 Treatment for chronic fatigue syndrome is symptom-based and includes p

113 Mortality associated with chronic fatigue syndrome is uncertain.

114 Chronic fatigue syndrome is unlikely to be caused or mai

115 Reports of mild hypocortisolism in chronic fatigue syndrome led us to postulate that low-do

116 tions, perception of health as fair or poor, chronic fatigue syndrome-like illness, and posttraumatic

117 In some patients with chronic fatigue syndrome, low-dose hydrocortisone reduce

118 Evidence also is beginning to emerge that chronic fatigue syndrome may be familial.

119 ical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM), we relied on expert cli

120 n patients with myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS), the data are limited

121 United States have myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).

122 (BD), schizophrenia (SZ), anxiety disorder, chronic fatigue syndrome, multiple sclerosis, amyotrophi

123 Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/

124 ted from the following 5 groups of patients: chronic fatigue syndrome (n = 32), human immunodeficienc

125 pathogenesis of non-GI autoimmune diseases, chronic fatigue syndrome, obesity and even some neuropsy

126 o association between XMRV and patients with chronic fatigue syndrome or chronic immunomodulatory con

127 ercise-associated syncope, eating disorders, chronic fatigue syndrome, or history of congenital heart

128 prostate cancer patients and in the blood of chronic fatigue syndrome patients.

129 physician-diagnosed multisymptom conditions: chronic fatigue syndrome, posttraumatic stress disorder,

130 rostate cancer and myalgic encephalomyelitis/chronic fatigue syndrome, recent data indicate that resu

131 was significantly lower in the subjects with chronic fatigue syndrome regardless of the presence or a

132 is the way in which chronic fatigue and the chronic fatigue syndrome relate to each other: Is one th

133 -related virus (XMRV) in prostate cancer and chronic fatigue syndrome reported in previous studies re

134 and the Trans-NIH Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Research Working Group.

135 The assessment and treatment of chronic fatigue syndrome should be multidimensional and

136 with an increased risk for fibromyalgia, the chronic fatigue syndrome, skin conditions, dyspepsia, an

137 se alterations are a cause or consequence of chronic fatigue syndrome still remains unanswered.

138 d worse health, or had a history of obesity, chronic fatigue syndrome, substance abuse, an eating dis

139 CD4(+) T cells and B cells of patients with chronic fatigue syndrome, suggesting an association betw

140 the Gulf War syndrome, chronic whiplash, the chronic fatigue syndrome, the irritable bowel syndrome,

141 c fatigue, and this is probably true for the chronic fatigue syndrome, too.

142 virus, XMRV, in blood cells of patients with chronic fatigue syndrome," two of the coauthors, Silverm

143 ng the Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome was cosponsored by the NIH Offi

144 havior therapy versus relaxation therapy for chronic fatigue syndrome were invited to complete self-r

145 trial, patients meeting Oxford criteria for chronic fatigue syndrome were recruited from six seconda

146 y (1.39, 0.60-2.73; p=0.45) in patients with chronic fatigue syndrome when compared with the general

147 rial of patients meeting Oxford criteria for chronic fatigue syndrome who were recruited from six sec

148 e can anticipate that discrete causes of the chronic fatigue syndrome will be found in the future, ev

149 32 patients met our strict criteria for chronic fatigue syndrome without co-morbid psychiatric d